As scientists scramble to come up with answers to halt the novel coronavirus in its tracks, which is currently spreading fast and wide, new research is coming in by the day, opening up new possibilities and pointing new directions to look in.
On 28 March, a paper (non-peer-reviewed) was released that drew a link between a vaccine that many in India know all too well and the volume or intensity of COVID-19 cases and deaths around the world.
I have joining me today on Swarajya Standard, Gobardhan Das. He is professor, molecular medicine, at Jawaharlal Nehru University, and he is one of the top immunologists in the country.
As you are no doubt aware, Swarajya is a media product that is directly dependent on support from its readers in the form of subscriptions. We do not have the muscle and backing of a large media conglomerate nor are we playing for the large advertisement sweep-stake.
Our business model is you and your subscription. And in challenging times like these, we need your support now more than ever.
We deliver over 10 - 15 high quality articles with expert insights and views. From 7AM in the morning to 10PM late night we operate to ensure you, the reader, get to see what is just right.
Becoming a Patron or a subscriber for as little as Rs 1200/year is the best way you can support our efforts.